|
|
|
|
||
Re: BP / BB salivatingI consider the potential of SGMO IP to be so much more valuable to a buyer. Than almost any BO in the past,,,,it is exponential. The potential of targets is ,,,,,limitless. both Uof MINN and Beckman School in CA are advancing in islet stem cell transplant for type I Diabetes,,,,,,as we speak. Is this Major? years away from clinic. But would be included in any consideration of a BO. BUYERS of whole companies look more at the calendar than at the clock. Their is no Biotech with the IP potential That SGMO has. There is no end in sight to the diseases that can be treated,,,if not "cured" using methods patented by SGMO. They know how and are improving their know how constantly, they just need to apply them. I can see the day when there are 10 0r 12 BP and BB with licenses of SGMO IP, for specific targets. I have no way of putting a current value on that kind of a future. "B" The process to "engineering genetic cures",,,,,,STARTS NOW. TICK TOCK. Damned if my Internet connection didn't fail just as the CC started. |
return to message board, top of board |